Fidelity Investments’s ASTEX PHARMACEUTICALS, INC COM ASTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2013
Q4
Sell
-60,000
Closed -$509K 2782
2013
Q3
$509K Sell
60,000
-3,384,917
-98% -$21.4M ﹤0.01% 2508
2013
Q2
$14.2M Buy
+3,444,917
New +$18.5M ﹤0.01% 1803

Fidelity Investments's ASTX Position: Q4 2013 in Review

Fidelity Investments sold out of ASTEX PHARMACEUTICALS, INC COM (ASTX) in Q4 2013, closing a stake of 60,000 shares — an estimated $509K sold.

Fidelity Investments first reported a position in ASTX in Q2 2013 and held it in 2 quarters. The position peaked at $14.2M in Q2 2013. 0 funds tracked by Wall St. Rank hold ASTX as of Q4 2013.

  • Fidelity Investments reported no remaining ASTEX PHARMACEUTICALS, INC COM position as of Q4 2013 after selling out during the quarter.
  • Fidelity Investments sold 60,000 ASTEX PHARMACEUTICALS, INC COM shares in Q4 2013, an estimated $509K.
  • Fidelity Investments first reported a position in ASTEX PHARMACEUTICALS, INC COM in Q2 2013 and held it in 2 quarters.
  • Fidelity Investments's ASTEX PHARMACEUTICALS, INC COM position peaked at $14.2M in Q2 2013.
  • 0 funds tracked by Wall St. Rank held ASTEX PHARMACEUTICALS, INC COM as of Q4 2013.

Based on Fidelity Investments's 13F filing for Q4 2013, filed 13 Feb 2014.